Testing a new diagnostic for mpox with skin samples
Part of Infections clinical trials.
This study is testing a new way to diagnose mpox by collecting fluid from skin blisters. It may help confirm if you have mpox more quickly and accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms that look like mpox, such as blisters or pustules (pus-filled bumps).
- You are at least 2 years old.
- You or your legal guardian can agree to take part in the study.
- If you are 12 to 17 years old, you and your guardian must both agree.
- Your symptoms started less than 15 days ago.
- You do not have only flat spots, bumps, or scabs—your skin should have blisters or pustules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.